Detailed price information for Protalix Biotherapeutics (PLX-A) from The Globe and Mail including charting and trades.
Crystalys Therapeutics has dosed the first patient with its once daily oral, URAT1 inhibitor dotinurad in its Phase II AMETHYST trial (NCT07535034), designed to assess dotinurad’s effectiveness in ...
Dutch data support continuation over discontinuation of urate-lowering therapy to achieve a serum urate level of 0.36 mmol/L ...
The European Alliance of Associations for Rheumatology - held its 2026 annual Congress in London, where gout was high on the ...
Last month, 18-year-old Australian sprinting sensation Gout Gout set up on the blocks of a sky-blue lane in Sydney for the final 200m event of the day. And then he made history: the teen thundered ...
18-year-old follows in A-listers’ footsteps on popular US show Appearance highlights growing global interest in young athlete It has previously been an honour reserved for the likes of Nicole Kidman ...
There may be no sport older than sprinting. And still, there's something singularly intoxicating about speed, about watching the fastest humans on the planet make like Usain Bolt and thunder down the ...
On the eve of an international campaign that culminates in an appearance at an iconic American track, Australian sensation Gout Gout has cracked the big time when profiled in a prime-time special that ...
Topline results from the phase 3 REDUCE 2 trial show that investigational pozdeutinurad effectively lowers serum uric acid in adults with gout.
In the bustling wellness market of 2026, a new product has captured significant attention: Kinzeno Triple Action Massage Gel.
With warmer temps come joyful signs of the summer season, like sandals and sundresses, but also the inevitable steamy weather that makes you break a sweat. If a basic face mist and cheap plastic fan ...
Nearly two-thirds (63%) of Americans with an overdue tax bill owe the IRS at least $10,000, according to a 2026 survey by LendEDU,, while more than 10% are behind by $100,000 or more. There are caps ...